Related Experiment Video
Updated: May 6, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Matrix metalloproteinases and their inhibitors in gastric cancer
G I Murray1, M E Duncan, E Arbuckle
1Department of Pathology, University of Aberdeen, UK.
Background:
The matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) are strongly implicated in tumour invasion and metastasis.
Aims:
To investigate the presence of individual MMPs and TIMPs in gastric cancer.
Methods:
The presence of MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1, and TIMP-2 was identified in a group of gastric cancers (n=74) by immunohistochemistry using monoclonal antibodies. These antibodies were effective on formalin fixed, paraffin wax embedded sections.
Results:
A large proportion (94%) of gastric cancers contained MMP-2; MMP-1 and MMP-9 were also detected in 73% and 70% of tumours respectively. MMP-3 was only present in 27% of tumours. MMP-1 and MMP-9 were found predominantly in intestinal type tumours. TIMP-1 and TIMP-2 were identified in 41% and 57% of tumours respectively. Immunoreactivity for individual MMPs or TIMPs was not identified in normal stomach.
Conclusions:
This study shows the presence of matrix metalloproteinases, particularly MMP-2, and TIMPs in stomach cancer. Antibodies which are effective in formalin fixed, paraffin wax embedded sections are useful for the identification of MMPs and TIMPs in diagnostic specimens.
Insights
Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) are present in stomach cancer. This study identified specific MMPs and TIMPs in gastric tumors, aiding in diagnosis.
Area of Science:
- Oncology
- Biochemistry
- Cancer Research
Background:
- Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) are crucial in tumor invasion and metastasis.
- Understanding the specific roles of MMPs and TIMPs in gastric cancer is essential for targeted therapies.
Purpose of the Study:
- To investigate the expression of specific matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in gastric cancer tissues.
- To evaluate the utility of immunohistochemistry with validated antibodies for detecting these proteins in formalin-fixed, paraffin-embedded samples.
Main Methods:
- Immunohistochemistry was employed to detect MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1, and TIMP-2 in 74 gastric cancer specimens.
- Monoclonal antibodies effective on formalin-fixed, paraffin-embedded sections were utilized for protein identification.
Main Results:
- Matrix metalloproteinase-2 (MMP-2) was detected in 94% of gastric cancers, with MMP-1 (73%) and MMP-9 (70%) also frequently observed.
- MMP-1 and MMP-9 expression was more prevalent in intestinal-type gastric tumors.
- Tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) and TIMP-2 were found in 41% and 57% of tumors, respectively; no MMPs or TIMPs were detected in normal stomach tissue.
Conclusions:
- Matrix metalloproteinases, particularly MMP-2, and TIMPs are present in stomach cancer.
- The validated antibodies are effective tools for identifying MMPs and TIMPs in diagnostic gastric cancer specimens.
More Related Videos
07:32Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
01:23Role of Matrix Metalloproteases in Degradation of ECM
01:26Gastritis II: Pathophysiology